期刊文献+

他克莫司对大鼠肝细胞膜胰岛素受体影响的研究 被引量:3

Effects of tacrolimus on insulin receptors in rat hepatocytic membrane
下载PDF
导出
摘要 目的通过观察他克莫司(FK506)对大鼠肝细胞膜胰岛素受体(IR)的作用,以期探讨FK506对糖代谢影响的可能机制。方法雄性纯系SD大鼠按不同浓度的FK506[0.1、1、3mg/(kg·d)]分别灌胃给药,2周后处死大鼠取肝脏进行肝细胞膜受体结合反应,用放免法测定IR的结合能力。结果FK506处理组大鼠肝细胞膜高亲和力IR亲和常数(K1)及低亲和力IR亲和常数(K2)均无显著变化;高浓度[1、3mg/(kg·d)]处理组大鼠肝细胞膜高亲和力IR结合位点浓度(Q1)与对照组相比明显降低,低亲和力IR结合位点浓度(Q2)无明显变化,而低浓度[0.1mg/(kg·d)]处理组高、低亲和力IR结合位点浓度与对照组相比均无显著变化。结论高浓度FK506对大鼠肝细胞膜IR结合产生一定程度影响,提示这可能是FK506影响机体糖代谢的作用机制之一。 Objective To explore the effects of tacrolimus on insulin receptors in rat hepatocytic membrane and to document the possible metabolism of tacrolimus on glucose metabolism. Methods Tacrolimus was given through gastric tube with different doses of 0.1, 1.0 or 3.0 mg/(kg·d) for 2 weeks. The animals were sacrificed and the liver specimens were obtained and hepatocytic membrane was separated to measure the binding capacity of insulin receptor by radioimmunoassay technique, Results Affinity constant K1 and K2 of higher affinity receptor and lower affinity receptor did not change in three groups, but the binding sites concentration (Q1)of higher affinity receptor decreased and the binding sites concentration (Q2) of lower affinity receptor kept in normal range in the higher dose groups [ 1,3 mg/ (kg· d) ]. Conclusion Tacrolimus influenced the binding capacity of insulin receptor in rat hepatoeytic membrane, which might be another cause of hyperglycemia after tacrolimus usage.
出处 《临床外科杂志》 2006年第5期291-293,共3页 Journal of Clinical Surgery
基金 国家"973计划"项目资助(编号2003CB515501)
关键词 他克莫司 大鼠 细胞膜 胰岛索受体 tacrolimus rats liver cell membrane insulin receptor
  • 相关文献

参考文献11

  • 1Berney T,Buhler LH,Majno P,et al.Immunosuppression for pancreatic islet transplantation[J].Transplantation Proceedings,2004,36(2 Suppl):362S-366S.
  • 2Robertson RP,Davis C,Larsen J,et al.Pancreas and islet transplantation for patients with diabetes[J].Diabetes Care,2000,23(1):112-116.
  • 3Paty BW,Harmon JS,Marsh CL,et al.Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets[J].Transplantation,2002,73(3):353-357.
  • 4Collins PG,Skibba JL.Improved in in situ rat liver and perfusion technique[J].J Surg Res,1980,28(1):65-70.
  • 5Cuatrecausas P.Isolation of the insulin receptor of liver and fat cell membranes[J].Pro Nat Acad Sci USA,1972,69(2):318-322.
  • 6Bradford MM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding[J].Anal Biochem,1976,72:248-254.
  • 7Shiraishi S,Yokoo H,Kobayashi H,et al.Post-translational reduction of cell surface expression of insulin receptors by cyclosporine A.FK506 and rapamycin in bovine adrenal chromaffin cells[J].Neuroscience Letters,2000,293(3):211-215.
  • 8Van Hooff JP,van Duijnhoven EM,Christiaans MH.Tarscrolimus and glucose metabolism[J].Transplant Proc,1999,31(7A):49S-50S.
  • 9Maes BD,Kuypers D,Messiaen T,et al.Post-transplantation diabetes mellitus in FK506 treated renal transplant recipients:analysis of incidence and risk factors[J].Transplantation,2001,72(10):1655-1661.
  • 10Nam JH,Mun JI,Kim SI,et al.Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus[J].Transplantation,2001,71(10):1417-1423.

同被引文献52

  • 1陈恺杰,唐群业.普乐可复在肾移植中的临床应用探讨[J].河北医学,2005,11(7):626-628. 被引量:7
  • 2王振,高江平,罗芸,卢锦山,敖建华,肖序仁,洪宝发,石炳毅,薛毅珑.不同浓度他克莫司在体外对胰岛的毒性作用及致糖尿病作用的临床研究[J].中华器官移植杂志,2006,27(11):681-684. 被引量:15
  • 3Revanur VK,Jardine AG,Kingsmore DB.Influence of diabetesmellitus on patient and graft survival in recipients of kidney trans-plantation[J].Clin Transplant,2001,15(2):89-94.
  • 4Gonzalez-Posada JM,Hernandez D,Genis BB.Increased cardio-vascular risk profile and mortality in kidney allograft recipientswith post-transplant diabetes mellitus in Spain[J].Clin Trans-plant,2006,20(5):650-658.
  • 5Kasiske B,Snyder JJ,Gilbertson D,et al.Diabetes mellitus afterkidney transplantation in the United States[J].Am J Trans-plant.2003;3(2):178-185.
  • 6Mazali FC,Lalli CA.,Alves-Filho G,et al.Posttransplant dia-betes mellitus:incidence and risk factors[J].Transplant Proc.2008,40(3),764-766.
  • 7Sharma A.,Minz M,Singh S,et al.Incidence of glucose meta-bolic abnormalities in Indian living renal allograft recipients on ta-crolimus-based triple drug immunosuppression[J].TransplantProc.2008,40(7),2414-2415.
  • 8Veroux M,Corona D,Giuffrida G,et al.New-onset diabetesmellitus after kidney transplantation:The role of immunosuppres-sion[J].Transplant Proc.2008,40(6):1885-1887.
  • 9Johnston O,Rose CL,Webste AC,et al.Sirolimus is associatedwith new-onset diabetes in kidney transplant recipients[J].JAm Soc Nephrol.2008,19(7):1411-1418.
  • 10Nassar CA,Nassar PO,Andia DC,et al.Biochemical evalua-tion of glycemic levels of long-term tacrolimus therapy in rats[J].Braz Oral Res,2007,21(4):293-297.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部